W
William C. Hahn
Researcher at Harvard University
Publications - 515
Citations - 85047
William C. Hahn is an academic researcher from Harvard University. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 130, co-authored 448 publications receiving 72191 citations. Previous affiliations of William C. Hahn include Brigham and Women's Hospital & University of Washington.
Papers
More filters
Journal Article
Clinical signs for the early recognition of cancer of the oral cavity.
TL;DR: An examination procedure is set out which every dentist should follow before any treatment is given, to make it possible to detect those carcinomas of which the patient himself is not yet aware.
Journal ArticleDOI
PROFILE: Broadly based genomic testing for all patients at a major cancer center.
Barrett J. Rollins,Laura E. MacConaill,Nikhil Wagle,Elizabeth P. Garcia,Frank C. Kuo,Janina A. Longtine,Judy Garber,Katherine A. Janeway,Charles S. Fuchs,Monica M. Bertagnolli,Robert J. Soiffer,Ursula A. Matulonis,Nan Lin,William C. Hahn,Levi A. Garraway,Philip W. Kantoff,Neal I. Lindeman +16 more
TL;DR: An "umbrella" protocol governing PROFILE activity, a highly simplified 2-page consenting brochure, and a centralized consenting process are developed, which created process flows for retrieving clinical specimens and performing OncoMap in a CLIA-certified laboratory.
Journal ArticleDOI
Global mobility, travel and migration health: clinical and public health implications for children and families.
Elizabeth Dawson-Hahn,Elizabeth Dawson-Hahn,Vaidehi Pidaparti,William C. Hahn,William M. Stauffer +4 more
TL;DR: It is critical to the health of all age groups to ensure that tailored guidance for children is considered in public health policy and guidelines, and pandemic responses, and to further support pandemic preparedness.
Journal ArticleDOI
2905 Genomic characterization of brain metastases and paired primary tumors reveals branched evolution and potential therapeutic targets
Priscilla Kaliopi Brastianos,Scott L. Carter,Sandro Santagata,Daniel P. Cahill,Amaro Taylor-Weiner,Robert T. Jones,Keith L. Ligon,J. Tabernero,Joan Seoane,E. Martinez Saez,Bruce E. Johnson,Toni K. Choueiri,Anat Stemmer-Rachamimov,Nan Lin,Rameen Beroukhim,Tracy T. Batchelor,José Baselga,David N. Louis,William C. Hahn,Gad Getz +19 more
Journal ArticleDOI
VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system
Jonathan So,Nathaniel W. Mabe,Bernhard Englinger,Kin-Hoe Chow,Sydney M. Moyer,Smitha Yerrum,Maria Trissal,Joana Graca Marques,Jason J. Kwon,Brian H Shim,Sangita Pal,Eshini Panditharatna,Thomas W. Quinn,Daniel A. Schaefer,Dae Hune Jeong,David L. Mayhew,Justin H. Hwang,Rameen Beroukhim,Keith L. Ligon,Kimberly Stegmaier,Mariella G. Filbin,William C. Hahn +21 more
TL;DR: Combining genome-scale CRISPR/Cas9 loss-of-function screens coupled with RNA-sequencing found that cancers of nervous system lineage required the nuclear kinase Vaccinia-Related Kinase 1 (VRK1) for their survival in vivo.